Patent · US Expired

Bradykinin antagonist

US6075120A · kind A · utility

17Cited by
2References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 12, 1995
Grant dateJun 13, 2000
Priority date
Expiry dateMay 12, 2015

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A bradykinin antagonist of the formula: EQU (BKAn)(X)(Y) where BKAn is a bradykinin antagonist peptide; Y is a pharmacore; and X is a bridging link chemically joining the BKAn and Y components.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.